Roche Holding AG (
OTCMKTS:RHHBY -
Get Free Report)'s stock price hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $45.08 and last traded at $44.83, with a volume of 2653804 shares changing hands. The stock had previously closed at $41.81.
Roche Price Performance
The stock has a fifty day moving average price of $40.61 and a 200-day moving average price of $40.26.
Institutional Trading of Roche
A number of institutional investors have recently made changes to their positions in RHHBY. GAMMA Investing LLC boosted its position in shares of Roche by 6,463.8% in the 1st quarter. GAMMA Investing LLC now owns 528,778 shares of the company's stock worth $21,759,000 after purchasing an additional 520,722 shares in the last quarter. Rhumbline Advisers boosted its position in shares of Roche by 7.4% in the 1st quarter. Rhumbline Advisers now owns 107,252 shares of the company's stock worth $4,413,000 after purchasing an additional 7,374 shares in the last quarter. Fulton Bank N.A. boosted its position in shares of Roche by 2.6% in the 1st quarter. Fulton Bank N.A. now owns 12,620 shares of the company's stock worth $518,000 after purchasing an additional 314 shares in the last quarter. Bard Financial Services Inc. boosted its position in shares of Roche by 25.3% in the 1st quarter. Bard Financial Services Inc. now owns 138,900 shares of the company's stock worth $5,716,000 after purchasing an additional 28,050 shares in the last quarter. Finally, Riverbridge Partners LLC boosted its position in shares of Roche by 6.7% in the 1st quarter. Riverbridge Partners LLC now owns 37,826 shares of the company's stock worth $1,557,000 after purchasing an additional 2,381 shares in the last quarter.
About Roche
(
Get Free Report)
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Roche, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Roche wasn't on the list.
While Roche currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
